ModuLight.bio

Company Overview

Snapshot

Founded in April 2022 by Ofir Levi, Yotam Eldar, and Daniel Sadot, ModuLight.bio operates with 11–50 employees. The company has raised $6.7 million across two funding rounds from six investors.

Business overview

ModuLight.bio is a Health Tech & Life Sciences company developing an optogenetics-based platform designed to treat neuronal overactivation disorders. The company's core technology aims to revolutionize the treatment of severe neurological conditions for millions globally. ModuLight.bio operates within the Pharmaceuticals, Life Sciences, and Healthcare & Life Sciences industries, focusing on drugs discovery and development, utilizing biologicals and cells.

Company Intelligence Q&A

What is ModuLight.bio's primary focus?

ModuLight.bio is developing an optogenetics-based platform for treating neuronal overactivation disorders, aiming to revolutionize the treatment of severe neurological conditions.

When was ModuLight.bio founded?

ModuLight.bio was founded in April 2022.

Who are the founders of ModuLight.bio?

The co-founders of ModuLight.bio are Ofir Levi, Yotam Eldar, and Daniel Sadot.

How much capital has ModuLight.bio raised to date?

ModuLight.bio has raised a total of $6.7 million across two funding rounds.

Which investors participated in ModuLight.bio's July 2025 funding round?

In July 2025, ModuLight.bio secured a funding round led by Nexus NeuroTech Ventures, with participation from.